Skip to main content
Division of Allergy & Immunology Division of Allergy & Immunology
  1. HOME
  2. Education
  3. Fellowship Program
  4. Collaboration

Collaborative Clinical/Research Initiatives

The US HAEA Angioedema Center serves as an international referral center for angioedema clinical care and education efforts, and additionally provides numerous research opportunities for fellows and residents. This includes bench, translational, and clinical research focused on angioedema conditions. The Angioedema Center has an active biomarker research program studying genetics/genomics and biochemical assays aimed at improving the diagnosis and management of angioedema conditions. Angioedema Center faculty are also focused on the design and conduct of numerous clinical trials for investigational angioedema therapies including biologics, targeted oral medications, and gene therapies. In collaboration with US HAEA Association, the Angioedema Center has developed and maintains a large HAE registry and biorepository as a valuable resource for angioedema research efforts.
US Hereditary Angiodema Center

 

Center for Asthma and Sinus Disease

Multidisciplinary center to advance diagnosis, treatment and research for airway disease including aspirin-exacerbated respiratory disease, severe asthma, and chronic sinusitis. Team consists of allergists, otolaryngologists, and pulmonologists who are actively involved in basic, translational and clinical research. UC San Diego and La Jolla Institute faculty collaborators are principle investigators of an NIH Asthma and Allergic Diseases Cooperative Research Center U19 grant. The Center for Asthma and Sinus Disease is also a designated World Allergy Organization Center of excellence.

Drug Allergy and Desensitization

Collaboration between the Division of Allergy, the Division of Infectious Diseases, the Department of Pharmacy, the Department of Hospital Medicine and Quality & Patient Safety to promote antibiotic stewardship and patient safety through the development of inpatient beta-lactam allergy evaluation and management pathways as well as specific testing initiatives in the transplant, pre-operative, cystic fibrosis, and surgical arenas

Rady Research Inititatives

  • NIH multi-center study with Boston Children’s on omalizumab to prevent asthma in toddlers 
  • U19 with Stanford and UCLA on omalizumab and dupilumab for multi-allergen OIT 
  • U19 with La Jolla Institute on milk allergy 
  • Collaboration with Rady Dermatology on Severe Eczema 
  • Collaboration with Rady Heme-Onc on WHIM syndrome 
  • Collaboration with Nephrology on immune evaluation before, during, and after immunosuppression  
  • Collaboration with Rady ED on Anaphylaxis management in the ED 
  • Public Health collaborations on asthma